Aeon Global Health Corp.: 10-Q filed 2014-05-15

Name: Aeon Global Health Corp.: 10-Q filed 2014-05-15
Creator: Aeon Global Health Corp.

What Aeon Global Health Corp. reported in its quarterly report filed 2014-05-15 (fiscal Q3 2014): 31 published measures, 86 facts as tagged in accession 0001193125-14-201236.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-05-15
Fiscal period: fiscal Q3 2014
Accession: 0001193125-14-201236 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Aeon Global Health Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-03-31	9,947,000	USD
At 2013-06-30	13,193,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-03-31	2,987,000	USD
At 2013-06-30	4,517,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-03-31	6,960,000	USD
At 2013-06-30	8,676,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-03-31	2,420,000	USD
At 2013-06-30	3,505,000	USD
At 2013-03-31	554,000	USD
At 2012-06-30	2,036,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,581,000	USD	90
2013-07-01 to 2014-03-31	-5,032,000	USD	274
2013-01-01 to 2013-03-31	-2,670,000	USD	90
2012-07-01 to 2013-03-31	-7,918,000	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-07-01 to 2014-03-31	-3,587,000	USD	274
2012-07-01 to 2013-03-31	-4,497,000	USD	274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	1,221,000	USD	90
2013-07-01 to 2014-03-31	4,486,000	USD	274
2013-01-01 to 2013-03-31	1,410,000	USD	90
2012-07-01 to 2013-03-31	3,382,000	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-03-31	-194,172,000	USD
At 2013-06-30	-188,837,000	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-03-31	503,000	USD
At 2013-06-30	733,000	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-07-01 to 2014-03-31	398,000	USD	274
2012-07-01 to 2013-03-31	238,000	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,682,000	USD	90
2013-07-01 to 2014-03-31	-5,006,000	USD	274
2013-01-01 to 2013-03-31	-1,858,000	USD	90
2012-07-01 to 2013-03-31	-5,734,000	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-03-31	6,957,000	USD
At 2013-06-30	9,184,000	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-03-31	2,855,000	USD
At 2013-06-30	4,333,000	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2014-03-31	50,000	USD
At 2013-06-30	50,000	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2014-03-31	2,130,000	USD
At 2013-06-30	2,310,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-03-31	659,000	USD
At 2013-06-30	566,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	2,903,000	USD	90
2013-07-01 to 2014-03-31	9,492,000	USD	274
2013-01-01 to 2013-03-31	3,268,000	USD	90
2012-07-01 to 2013-03-31	9,116,000	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2014-03-31	3,039,000	USD
At 2013-06-30	3,959,000	USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	835,000	USD	90
2013-07-01 to 2014-03-31	3,072,000	USD	274
2013-01-01 to 2013-03-31	1,004,000	USD	90
2012-07-01 to 2013-03-31	2,521,000	USD	274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	1,602,000	USD	90
2013-07-01 to 2014-03-31	5,071,000	USD	274
2013-01-01 to 2013-03-31	1,778,000	USD	90
2012-07-01 to 2013-03-31	5,140,000	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	275,000	USD	90
2013-07-01 to 2014-03-31	780,000	USD	274
2013-01-01 to 2013-03-31	273,000	USD	90
2012-07-01 to 2013-03-31	834,000	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-03-31	38,336,000	shares
At 2013-06-30	35,339,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-03-31	201,025,000	USD
At 2013-06-30	197,409,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-03-31	570,000	USD
At 2013-06-30	1,194,000	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2014-03-31	373,000	USD
At 2013-06-30	688,000	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,581,000	USD	90
2013-07-01 to 2014-03-31	-5,032,000	USD	274
2013-01-01 to 2013-03-31	-2,670,000	USD	90
2012-07-01 to 2013-03-31	-7,918,000	USD	274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,682,000	USD	90
2013-07-01 to 2014-03-31	-7,352,000	USD	274
2013-01-01 to 2013-03-31	-3,041,000	USD	90
2012-07-01 to 2013-03-31	-9,032,000	USD	274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	85,000	USD	90
2013-07-01 to 2014-03-31	250,000	USD	274
2013-01-01 to 2013-03-31	69,000	USD	90
2012-07-01 to 2013-03-31	206,000	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	101,000	USD	90
2013-07-01 to 2014-03-31	-26,000	USD	274
2013-01-01 to 2013-03-31	-812,000	USD	90
2012-07-01 to 2013-03-31	-2,184,000	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-07-01 to 2014-03-31	93,000	USD	274
2012-07-01 to 2013-03-31	352,000	USD	274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-07-01 to 2014-03-31	-920,000	USD	274
2012-07-01 to 2013-03-31	453,000	USD	274

Inspect the source

Entity: Aeon Global Health Corp. / CIK 0000885074
Captured: 2026-09-22 19:32 UTC
SEC response SHA-256: 676258e699121fefe9c98c84b5dc108599f9c9b7ab949788884327b4fa4543d3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000885074.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))